» Articles » PMID: 32138288

Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 Novel Variants

Abstract

Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal storage disorder caused by mutations in or genes. In 2009, the molecular characterization of 44 NPC Italian patients has been published. Here, we present an update of the genetic findings in 105 Italian NPC patients belonging to 83 unrelated families (77 NPC1 and 6 NPC2). and genes were studied following an algorithm recently published. Eighty-four different and five alleles were identified. Only two alleles remained non detected. Sixty-two percent of alleles were due to missense variants. The most frequent mutation was the p.F284Lfs*26 (5.8% of the alleles). All mutations were found in the homozygous state, and all but one was severe. Among newly diagnosed patients, 18 novel mutations were identified. The pathogenic nature of 7/9 missense alleles and 3/4 intronic variants was confirmed by filipin staining and NPC1 protein analysis or mRNA expression in patient's fibroblasts. Taken together, our previous published data and new results provide an overall picture of the molecular characteristics of NPC patients diagnosed so far in Italy.

Citing Articles

L. Methanol Extract and Its Component Rutin Reduce Cholesterol More Efficiently than Miglustat in Niemann-Pick C Fibroblasts.

Wanes D, Al Aoua S, Shammas H, Walters F, Das A, Rizk S Int J Mol Sci. 2024; 25(21).

PMID: 39518914 PMC: 11547104. DOI: 10.3390/ijms252111361.


Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC).

Stern S, Crisamore K, Schuck R, Pacanowski M Orphanet J Rare Dis. 2024; 19(1):280.

PMID: 39061081 PMC: 11282650. DOI: 10.1186/s13023-024-03233-7.


Challenges in the Definitive Diagnosis of Niemann-Pick Type C-Leaky Variants and Alternative Transcripts.

Encarnacao M, Ribeiro I, David H, Coutinho M, Quelhas D, Alves S Genes (Basel). 2023; 14(11).

PMID: 38002933 PMC: 10671040. DOI: 10.3390/genes14111990.


Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.

Freihuber C, Dahmani-Rabehi B, Brassier A, Broue P, Cances C, Chabrol B Orphanet J Rare Dis. 2023; 18(1):204.

PMID: 37480097 PMC: 10362619. DOI: 10.1186/s13023-023-02804-4.


At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years.

Guatibonza Moreno P, Pardo L, Pereira C, Schroeder S, Vagiri D, Almeida L Eur J Hum Genet. 2023; 31(10):1108-1116.

PMID: 37433892 PMC: 10545733. DOI: 10.1038/s41431-023-01408-7.


References
1.
Wassif C, Cross J, Iben J, Sanchez-Pulido L, Cougnoux A, Platt F . High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2015; 18(1):41-8. PMC: 4486368. DOI: 10.1038/gim.2015.25. View

2.
Fecarotta S, Romano A, Casa R, Del Giudice E, Bruschini D, Mansi G . Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C. Orphanet J Rare Dis. 2015; 10:22. PMC: 4359492. DOI: 10.1186/s13023-015-0240-y. View

3.
Millat G, Bailo N, Molinero S, Rodriguez C, Chikh K, Vanier M . Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. Mol Genet Metab. 2005; 86(1-2):220-32. DOI: 10.1016/j.ymgme.2005.07.007. View

4.
Rodriguez-Gil J, Watkins-Chow D, Baxter L, Elliot G, Harper U, Wincovitch S . Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1. Dis Model Mech. 2020; 13(3). PMC: 7075069. DOI: 10.1242/dmm.042614. View

5.
Ballestar E . Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol. 2011; 7(5):263-71. DOI: 10.1038/nrrheum.2011.16. View